Pharmafile Logo
Pharmafocus logo
Advanced Search

Pierre Fabre partners with Know Your Lemons Foundation for breast cancer awareness

October 2, 2025
Medical Communications Education, Pierre Fabre, breast cancer

The campaign focuses on early detection and education Pierre Fabre Laboratories has announced a partnership with the Know Your Lemons …

News
partnership

Nanoform partners with A&LS Pharma

October 2, 2025
Research and Development A&LS Pharma, Nanoform

Distribution agreement will make Nanoform’s products available in South Korea Nanoform Finland has entered into a distribution agreement with Ageing …

News

From Vaccine Innovation Pathway to growth powerhouse: how the UK is transforming clinical trials

October 2, 2025
Business Services, Market Access, Market Access Consultancy, Sales and Marketing 10 Year Health Plan, Life Sciences Sector Plan, NHS, National Institute for Health and Care Research, Pharmacy, UK Vaccine Innovation Pathway

Commercial clinical trials are a high-value growth driver for a country’s health and the economy and a key component of …

Feature
Thought Leadership

Five Facts about Breast Cancer

October 2, 2025
Medical Communications Breast Cancer Awareness Month, Five Facts, Oncology, breast cancer

1 There are striking inequities in breast cancer burden regarding the Human Development Index (HDI), the United Nation’s measure of …

Feature

Unlocking nature’s pharmacy: how tea leaves and marine organisms could help transform breast cancer treatment

October 2, 2025
Research and Development King Abdullah University of Science and Technology, Oncology, natural products chemistry, triple-negative breast cancer

Looking beyond synthetic chemistry to unlock powerful, naturally derived medicines Each year, World Breast Cancer Awareness Month serves as a …

Feature

Sanofi and Regeneron’s Dupixent receives CHMP recommendation for chronic spontaneous urticaria

September 26, 2025
Research and Development Dupixent, Regeneron, Sanofi, urticaria

Sanofi and Regeneron have received a positive opinion from the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human …

News
hsm_mobile_clinical_trial_istock-872676342

CSL Behring’s angioedema treatments receives NICE recommendation

September 26, 2025
Regulatory Affairs, Research and Development Andembry, CSL Behring, hereditary angioedema

The National Institute for Health and Care Excellence (NICE) has issued final draft guidance recommending CSL Behring’s ANDEMBRY (garadacimab) for …

News
drug-trials

Gilead Foundation awards $6.5m in grants to support STEM education

September 26, 2025
Research and Development Funding and Investment, Gilead Sciences, stem

Gilead Sciences has committed over $6.5m in grant funding towards improving science, technology, engineering and maths (STEM) education, the company …

News

Lilly opens fourth US Gateway Labs site

September 26, 2025
Research and Development Eli Lilly, Local Investment, biotech, life sciences

Eli Lilly has opened its newest Lilly Gateway Labs (LGL) site in San Diego, California, expanding its network of shared …

News
partnership

Arkivum and PHARMASEAL partner on trial management platform

September 26, 2025
Research and Development Arkivum, PHARMASEAL, Trial Management

Arkivum, a digital archiving and preservation solutions provider, has entered into a collaborative agreement with PHARMASEAL, a software company specialising …

News

Combination treatments: Takeda’s Implementation Framework and the broader landscape

September 23, 2025
Research and Development HIV/AIDS, Hepatology, NHS, NICE, Oncology, Takeda, combination therapy, oncology

Pharmafile talks to Emma Roffe, Oncology Country Head (UK & Ireland) about the combination treatment landscape and the impact of …

Feature
drug-trials

LGC Group opens $100M Organic Chemistry Synthesis Centre of Excellence

September 19, 2025
Medical Communications, Research and Development LGC Group, biotech, life sciences, pharma

LGC Group, a life sciences company, has opened its new Organic Chemistry Synthesis Centre of Excellence in Ontario, Canada after …

News
Lilly secures conditional MHRA approval for new blood cancer treatment

Crown Bioscience opens new US model development centre

September 19, 2025
Medical Communications, Research and Development CRO, biotech, crown bioscience, life sciences

Crown Bioscience, a US global contract research organisation (CRO) that is part of JSR Life Sciences and Japan-based JSR Corporation, …

News

UCB announces first-in-patient trial success for galvokimig in atopic dermatitis

September 18, 2025
Medical Communications, Research and Development Dermatology, UCB, atopic dermatitis, clinical trial

UCB has reported positive early clinical trial results for galvokimig, an investigational therapy for adults with moderate-to-severe atopic dermatitis (AD). …

News
mobile apps

electronRx to launch pDx app for remote monitoring of chronic respiratory disease

September 18, 2025
Research and Development Asthma & COPD, Devices, devices, electronRx, pDx, respiratory diseases (CRDs)

Digital medicine company electronRx, based in Cambridge, UK, has announced the upcoming launch of pDx, a mobile app designed to …

News

ProteoNic Biosciences launches platform to enhance cell line productivity

September 17, 2025
Research and Development Devices, ProteoNic Biosciences, cell line productivity, gene therapy

ProteoNic Biosciences, a biotech company headquartered in Leiden, Germany has unveiled its latest technology platform, the 2G UNic transposon system, developed …

News
handshake-2056023_960_720

NeoVac appoints Jan H Egberts as chief executive officer

September 17, 2025
Analytical & Laboratory Services, Business Services, Clinical Trial Services, Research and Development Devices, Lipid Nanoparticle Technology, Neovac, mRNA Therapies

NeoVac, a clinical-stage biopharma based in Abingdon, UK, has appointed Jan H Egberts as chief executive officer. The company is …

Appointment

PlasmidFactory founder Dr. Martin Schleef honoured with the NRW Innovation Award 2025

September 12, 2025
Innovation Award 2025, PlasmidFactory, cell and gene therapy, medical communications, research and development

The founder and long-standing CEO of PlasmidFactory, Dr. Martin Schleef, was honoured in Düsseldorf with the Innovation Award 2025 of …

News
Lilly secures conditional MHRA approval for new blood cancer treatment

Symeres announces acquisition of DGr Pharma

September 11, 2025
Medical Communications, Research and Development DGr Pharma, Symeres, biopharma, contract research

Symeres, a Contract Research, Development and Manufacturing Organization (CRDMO) has acquired DGr Pharma, a drug development-focused consultancy. The acquisition will …

News

Danny Wolin appointed as KJT’s Senior VP of real-world evidence

September 11, 2025
Medical Communications, Research and Development KJT, real-world evidence

Danny Wolin has been appointed as Senior Vice President of Real-World Evidence at KJT. KJT is an evidence-based healthcare consulting …

Appointment
The Gateway to Local Adoption Series

Latest content

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026

PSI appoints David Allen as Country Manager for Canada

January 22, 2026

Qureight appoints Steven Bishop as Chief Medical Officer

January 21, 2026

Pierre Fabre Laboratories and Iktos announce oncology collaboration

January 21, 2026

Qureight appoints Rebecca Simmons as Chief Operating Officer

January 20, 2026